4503.T JPX
Astellas Pharma Inc.
1W: -4.8%
1M: -5.3%
3M: +3.2%
YTD: -11.3%
1Y: +39.5%
3Y: +20.8%
5Y: +33.8%
¥2,226.00 ($14.09)
-19.00 (-0.85%)
Weekly Expected Move ±3.3%
¥2097
¥2171
¥2245
¥2319
¥2393
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$566.3B
+180.9% ▲
5Y CAGR: +13.0%
Capital Expenditures
$57.7B
-56.0% ▼
5Y CAGR: -5.7%
Free Cash Flow
$508.5B
+208.9% ▲
5Y CAGR: +17.3%
Dividends Paid
$136.1B
-5.5% ▼
Buybacks
$730M
+89.5% ▲
Net Change in Cash
$93.2B
+163.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $156.9B | $132.4B | $17.0B | $50.7B | $291.5B |
| Depreciation & Amort. | $79.7B | $105.7B | $157.8B | $199.1B | $194.6B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$10.7B | $74.0B | -$81.2B | -$147.7B | $27.4B |
| Other Non-Cash Items | $31.6B | $15.7B | $78.8B | $99.5B | $52.7B |
| Operating Cash Flow | $257.4B | $327.8B | $172.5B | $201.6B | $566.3B |
| — Investing Activities — | |||||
| Capital Expenditures | -$76.4B | -$88.5B | -$38.1B | -$57.3B | -$84.6B |
| Acquisitions (Net) | -$670M | $0 | -$785.0B | $0 | $0 |
| Investment Purchases | -$5.6B | $0 | $0 | $0 | $0 |
| Investment Sales | $5.6B | $12.6B | $0 | $12.9B | $0 |
| Other Investing | $14.7B | -$8.6B | -$22.8B | -$52.1B | $11.9B |
| Investing Cash Flow | -$62.4B | -$84.5B | -$845.8B | -$96.5B | -$72.8B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$60.0B | -$15.0B | $771.2B | -$88.5B | -$267.4B |
| Stock Repurchased | -$50.7B | -$60.6B | -$10.7B | -$7.0B | -$730M |
| Dividends Paid | -$85.2B | -$100.4B | -$116.7B | -$129.0B | -$136.1B |
| Other Financing | -$20.3B | -$19.7B | -$29.8B | -$36.9B | -$532M |
| Financing Cash Flow | -$216.3B | -$195.6B | $614.1B | -$261.4B | -$404.8B |
| Net Change in Cash | -$10.1B | $60.9B | -$41.2B | -$147.3B | $93.2B |
| Cash End of Period | $316.0B | $376.8B | $335.7B | $188.4B | $281.6B |
| Free Cash Flow | $181.0B | $239.2B | $90.0B | $164.6B | $508.5B |